High Tower Advisors, LLC Pfizer Inc Put Options Transaction History

High Tower Advisors, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $70,728 - $82,880	2,800 New	2,800 $78,000
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $25,084 - $32,582	960 Added 2400.0%	1,000 $28,000
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $1,283 - $1,500	40 New	40 $1,000
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $197,146 - $256,656	5,005 Added 5268.42%	5,100 $208,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $417 - $545	10 Added 11.76%	95 $4,000
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $350,736 - $428,161	-8,015 Reduced 98.95%	85 $19,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $373,124 - $442,408	8,019 Added 9900.0%	8,100 $12,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $2,241 - $2,777	49 Added 153.13%	81 $14,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $1.32 Million - $1.95 Million	-31,868 Reduced 99.9%	32 $78,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $1.25 Million - $1.6 Million	31,800 Added 31800.0%	31,900 $11,000
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $2,009 - $2,266	60 Added 150.0%	100 $9,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $1,338 - $1,702	40 New	40 $1,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.